Literature DB >> 9435922

Cost-effectiveness analysis of day care for patients with dementia disorders.

A Wimo1, B Mattsson, I Krakau, T Eriksson, A Nelvig.   

Abstract

In a cost-effectiveness analysis, the costs of 55 demented patients in day care (DC) and 45 patients on a waiting list were related to the effects on indices measuring quality of life. Based on one year's study, the costs per patient per day, was USD 55 for the DC-group and USD 63 for the controls (p > 0.05). Both groups deteriorated in the indices during the study year. The trend was that DC was both cheaper and better in the indices, and some of the underlying variables for the used indices also showed significantly better results in favour of DC. However, since the changes between the groups were not significant regarding the basic question at issue, it cannot be stated that DC is more cost-effective than a care organisation without DC. Different interpretations of the results are presented.

Entities:  

Mesh:

Year:  1994        PMID: 9435922     DOI: 10.1002/hec.4730030607

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  4 in total

1.  Cost of Alzheimer's disease.

Authors:  M Davidson; M Schnaider Beeri
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

2.  Unmet Needs for Family Caregivers of Elderly People With Dementia Living in Italy: What Do We Know So Far and What Should We Do Next?

Authors:  Maria C De Cola; Viviana Lo Buono; Agata Mento; Mariella Foti; Silvia Marino; Placido Bramanti; Alfredo Manuli; Rocco S Calabrò
Journal:  Inquiry       Date:  2017-01-01       Impact factor: 1.730

3.  The impact of attending day care designed for home-dwelling people with dementia on nursing home admission: a 24-month controlled study.

Authors:  Anne Marie Mork Rokstad; Knut Engedal; Øyvind Kirkevold; Jūratė Šaltytė Benth; Geir Selbæk
Journal:  BMC Health Serv Res       Date:  2018-11-16       Impact factor: 2.655

4.  Cost analysis of day care centres in Norway.

Authors:  C Vossius; G Selbæk; J Šaltytė Benth; A Wimo; K Engedal; Ø Kirkevold; A M M Rokstad
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.